Skip to content

HeartStart FRx Defibrillator Event Registry

HeartStart FRx Defibrillator Event Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04250857
Enrollment
1400
Registered
2020-01-31
Start date
2019-11-04
Completion date
2030-12-31
Last updated
2026-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sudden Cardiac Arrest

Brief summary

This post market clinical follow-up study is a multi-center, non-randomized, unblinded, observational registry of the performance of the FRx Automated external defibrillator (AED) used in conjunction with electrodes with or without use of the infant/child key. The registry is focused only on on post-event data collection and does not prescribe any device usage. This registry has several safeguards in place to prevent against selections bias, including enrollment of all participants who have pads placed. This registry will evaluate the safety and verify the clinical performance of the device in relation to its claims, when used in accordance with the Device Manual.

Interventions

DEVICEHeartStart FRX

Automated External Defibrillator

Sponsors

Heartstream US LLC
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Subjects accepted into the study must: have been suspected of a circulatory arrest for any cause * Have had HeartStart FRx AED with electrodes: HeartStart SMART PADS II applied to their body and powered up, regardless of whether a defibrillation shock was delivered

Exclusion criteria

* AED or pad use other than the HeartStart FRx AED with electrodes : HeartStart SMART PADS II * AED used for training purposes.

Design outcomes

Primary

MeasureTime frameDescription
Algorithm accuracyUp to 15 minutes after device placementAlgorithm performance as determined by adjudication of the wave form data as aligned with the device advisement.
Shock Delivery1 dayPercentage of events where a shock was delivered when indicated.
Unexpected adverse events.1 dayFrequency and severity of unexpected adverse events.
Unanticipated adverse device effects (UADE)1 dayUnanticipated adverse device effects (UADE)

Secondary

MeasureTime frameDescription
Time Intervals1 dayMeasurements of device performance time intervals.
Device Preparation1 dayPercentage of events where the device prepared to shock.
Shock Energy Delivered1 dayThe amount of shock energy delivered as measured in joules with each shock.
Pad Replacement1 dayFrequency of pad replacement.
User1 dayFrequency of user pressing the shock button.

Countries

United States

Contacts

CONTACTBarb Fink
barb.fink@philips.com724-708-7048

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 12, 2026